Description: Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products in India, the United States, and internationally. It offers pharma products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management; and active pharmaceutical ingredients. The company was founded in 1944 and is based in Mumbai, India.
Home Page: www.unichemlabs.com
Unichem Bhavan
Mumbai,
400102
India
Phone:
91 22 6688 8333
Officers
| Name | Title |
|---|---|
| Dr. Prakash Amrut Mody | Chairman & MD |
| Mr. Sandip Ghume | Deputy Chief Financial Officer |
| Mr. Dilip Kunkolienkar | Director of Technical & Whole-Time Director |
| Mr. Pradeep Kumar Bhandari | Head of Legal, Company Sec. & Compliance Officer |
| Mr. Prasad Joshi | VP of HR & ER |
| Mr. Vinod Kumar Behl | Head of Projects & Investments |
| Mr. Bhagwat S. Dhingra | Chief Exec. of Domestic Pharma |
| Mr. Scott B. Delaney | Pres of North America & CEO of North America |
| Dr. P. B. Deshpande M.Sc. Ph.D. | VP of Chemical of R&D |
| Ms. Supriya Prakash Mody | Associate VP of International Bus. |
Exchange: BSE
Country: IN
Currency: Indian Rupee (INR)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.6456 |
| Price-to-Sales TTM: | 1.3378 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 0 |